NVIDIA’s (NVDA) “Buy” Rating Reiterated at Bank of America
otakuyassine3@gmail.com Bank of America reissued their buy rating on shares of NVIDIA (NASDAQ:NVDA – Free Report)...
Reiterated
Corbus Pharmaceuticals’ (CRBP) Buy Rating Reiterated at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report)...
CrowdStrike’s (CRWD) “Overweight” Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of CrowdStrike (NASDAQ:CRWD – Free Report) in...
CrowdStrike’s (CRWD) “Neutral” Rating Reiterated at Guggenheim
Guggenheim reissued their neutral rating on shares of CrowdStrike (NASDAQ:CRWD – Free Report) in a...
Cinemark’s (CNK) Outperform Rating Reiterated at Barrington Research
Barrington Research reiterated their outperform rating on shares of Cinemark (NYSE:CNK – Free Report) in...
1-800-FLOWERS.COM’s (FLWS) “Neutral” Rating Reiterated at DA Davidson
1-800-FLOWERS.COM (NASDAQ:FLWS – Get Free Report)‘s stock had its “neutral” rating reissued by DA Davidson...
Citizens Financial Group’s (CFG) “Overweight” Rating Reiterated at Stephens
Stephens reaffirmed their overweight rating on shares of Citizens Financial Group (NYSE:CFG – Free Report)...
A. O. Smith’s (AOS) “Hold (C)” Rating Reiterated at Weiss Ratings
A. O. Smith (NYSE:AOS – Get Free Report)‘s stock had its “hold (c)” rating restated...
Blueprint Medicines’ (BPMC) Outperform Rating Reiterated at Wedbush
Wedbush reaffirmed their outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in...
Day One Biopharmaceuticals’ (DAWN) “Buy” Rating Reiterated at Needham & Company LLC
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “buy” rating reissued by...